| abstract |
The invention provides new compounds pertaining to the class of: aryl methoxy phenyl alkyl heterocyclic spiro compounds, enantiomers, diastereoisomers and physiologically-tolerable salts thereof. For example: 8-{2-[3-quinol-2-yl methoxy)phenyl]ethyl}-3,8-diaza-1-oxa-2-oxo spiro[4,5]decane is described. Medicinal products containing the same are useful in the treatment of any pathology involving modifications of leukotriene metabolism. |